Given the robust correlations of FAK/PTK2 with TGCT, KIRC, CHOL, KIRP, READ, UVM, BLCA, and SARC, we performed GSEA to investigate the potential pathways involved in FAK/PTK2 signaling in these cancers. Here, PTK2 is linked to cancer.